OGI Hold Rating Maintained by Stifel GMP - C$1.50 Target2022-07-15 11:15:40 AM ET (MT Newswires)
11:15 AM EDT, 07/15/2022 (MT Newswires) -- Stifel GMP on Friday reiterated its hold rating on the shares of Organigram Holdings (OGI.TO) with a C$1.50 price target following release of the cannabis producer's fiscal third-quarter results.
"OGI reported impressive revenue sequential growth in Q3FY22 (ending May 2022), however improving profitability continued to prove elusive with a gross margin decline, likely due to lower contribution of high margin international sales," analyst Andrew Partheniou writes. "While those accretive opportunities are expected to rebound next quarter, we believe sustainable success is predicated on reaching profitability with its core market, Canada. While near-term production expansion is expected to support margin expansion through operating leverage, our visibility remains cloudy as to ultimate potential levels given market share capture has traditionally stemmed from value products with lesser margin profiles."